Journal of

Clinical Gastroenterology and TreatmentISSN: 2469-584X

Early Online

 Open Access DOI:10.23937/2469-584X/1510086

Improved Electrolyte and Fluid Balance Results in Control of Diarrhea with Crofelemer in Patient with Short Bowel Syndrome: A Case Report

William Powers, DO

Article Type: Case Report | First Published: May 09, 2022

Short bowel syndrome (SBS) is a rare malabsorptive disorder characterized by the inability to maintain a balance of fluids, electrolytes, and nutrients when taking a conventional diet. SBS can cause chronic, severe diarrhea and malnutrition, often requiring dependence on parenteral nutrition. We present the case of a 55-year-old female with a complete colectomy and partial small bowel resection who experienced chronic, severe diarrhea for over a decade, resulting in her being housebound and maln...

 Open Access DOI:10.23937/2469-584X/1510085

The Potential to Lower the Incidence of Necrotising Enterocolitis with Branched Chain Fatty Acids

Luke M. Bosnar, Anya E. Shindler, Jennifer Wood, Craig Patch and Ashley E. Franks

Article Type: Review Article | First Published: May 08, 2022

Necrotising enterocolitis is an intestinal inflammatory disease, with the highest rate of incidence occurring in premature infants born before 36-weeks, due to infants missing out on the in-utero ingestion of vernix caseosa. The in-utero consumption of vernix caseosa is a key biological process, necessary for the effective and healthy modulation of the infant’s intestinal microbiome, as the branched chain fatty acid content of vernix caseosa allows many branched chain fatty acid commensal bact...

 Open Access DOI:10.23937/2469-584X/1510084

CD 90 as Cancer Stem Cell Biomarker in Liver Cancer

Mohamed Hussein

Article Type: Research Paper | First Published: March 25, 2022

Liver cancer is the end-stage of chronic liver diseases. The main aetiologies of chronic liver diseases CLDs are chronic hepatitis C virus (HCV) infection. The aim of this work was to evaluate diagnostic value of CD-90 in patients with chronic liver disease (CLD) Fibrosis, Liver cancer and healthy individuals. The present study included Fibrotic patients, Liver cancer patients, in addition individuals were enrolled in this study as control group. AFP and CEA were estimated in all groups. CD-90 w...

Volume 8
Issue 1